Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128964) titled 'Mechanism of Gut-Derived Signaling Molecules in Blood Glucose Control and Gut Protection' on July 29.
Study Type: Observational study
Study Design:
Factorial
Primary Sponsor: Shanghai Tenth People's Hospital
Condition:
Type 2 Diabetes Mellitus with Intestinal Mucosal Barrier Dysfunction
Intervention:
Inflammatory Bowel Disease with Diabetes Mellitus Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Inflammatory Bowel Disease with Diabetes Mellitus Group:40;healthy control group:40;
Countries of Recruitment:
China
To know more, visit h...